Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Acquisitions (2023)

Perspective Therapeutics (CATX) has disclosed Acquisitions for 1 consecutive years, with $2.7 million as the latest value for Q1 2023.

  • Quarterly Acquisitions changed N/A to $2.7 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2023, changed N/A year-over-year, with the annual reading at $2.7 million for FY2023, N/A changed from the prior year.
  • Acquisitions hit $2.7 million in Q1 2023 for Perspective Therapeutics.
  • In the past five years, Acquisitions ranged from a high of $2.7 million in Q1 2023 to a low of $2.7 million in Q1 2023.